Schedule 13G ownership disclosure
Atea Pharmaceuticals Inc
COMMON STOCK · CUSIP: 04683R106
Event date: 2025-11-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 9,095,679.87 · Class: 11.6%
- Abigail P. Johnson
Shares: 9,095,679.87 · Class: 11.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-25-002957
- Form type
- SCHEDULE 13G/A
- Filer
- Atea Pharmaceuticals, Inc.
- CIK
- CIK 1593899
- Filed
- Dec 05, 2025
- Reporting period
- Nov 28, 2025
- Description
- Schedule 13G beneficial ownership